natgillin/translations-raw huggingface dataset:
Budesonid/Formoterol Teva Pharma B.V.’s farmakokinetisk profil
Budesonide/Formoterol Teva Pharma B.V. pharmacokinetic profile
Budesonid/Formoterol Teva Pharma B.V.’s sikkerhed og virkning hos børn i alderen 12 år og derunder og unge i alderen 13-17 år er endnu ikke klarlagt.
The safety and efficacy of Budesonide/Formoterol Teva Pharma B.V. in children, 12 years and younger and adolescents, 13 to 17 years of age has not yet been established.
Budesonid/formoterolfurmaratdihydrat 320/9 µg to gange dagligt + terbutalin 0,4 mg efter behov
Budesonide/Formoterol Furmarate Dihydrate 320/9 µg bd + terbutaline 0.4 mg as needed
Budesonide/Formoterol Teva anvendes desuden til dæmpe symptomerne på svær kronisk obstruktiv lungesygdom (KOL) hos voksne, der tidligere har haft anfald med forværring af sygdommen trods regelmæssig behandling.
Budesonide/Formoterol Teva is also used to relieve the symptoms of severe chronic obstructive pulmonary disease (COPD) in adults who have had exacerbations (flare–ups) of the disease in the past despite regular treatment.
Budesonide/Formoterol Teva er et “hybridt lægemiddel”.
Budesonide/Formoterol Teva is a ‘hybrid medicine’.
Budesonide/Formoterol Teva Pharma B.V. er et lægemiddel, der indeholder de to aktive stoffer budesonid og formoterol.
Budesonide/Formoterol Teva Pharma B.V. is a medicine that contains the active substances budesonide and formoterol.
Budesonide/Formoterol Teva Pharma B.V. er et “hybridt lægemiddel”.
Budesonide/Formoterol Teva Pharma B.V. is a ‘hybrid medicine’.
Budesonide/Formoterol Teva Pharma B.V. kan anvendes til regelmæssig behandling af astma.
Budesonide/Formoterol Teva Pharma B.V. can be used for the regular treatment of asthma.
Buffer hætteglas: 3 ml
Buffer vial: 3 ml
Bug ikke mere creme end din læge har rådet dig til.
Do not use more cream than your doctor has advised.
bughindebetændelse (peritonitis)
inflammation of the lining of the abdominal cavity (peritonitis)
bughindebetændelse, sure opstød, smerter i gummerne, udspilet mave
inflammation of the peritoneum (the tissue that lines most of the organs of the abdomen), unusual backflow of food from stomach, gum pain, abdominal distension
bughulebetændelse
infection within the abdomen
Bugspytkirtel
Pancreas
Bugspytkirtel3
Pancreas3
Bugspytkirtlen
Pancreas
Buiten het zicht en bereik van kinderen houden.
Keep out of the sight and reach of children.
Bukkale sygdomme
Gingival disorders
Bukkaltabletterne er flade, runde tabletter med skrå kanter, præget på den ene side med et “C” og på den anden side med “1” for Effentora 100 mikrogram, med “2” for Effentora 200 mikrogram, med “4” for Effentora 400 mikrogram, med “6” for Effentora 600 mikrogram og med “8” for Effentora
The buccal tablets are flat-faced, round bevelled-edge tablet, embossed one side with a “C” and on the other side with “1” for Effentora 100 micrograms, with “2” for Effentora 200 micrograms, with “4” for Effentora 400 micrograms, with “6” for Effentora 600 micrograms, with “8” for Effentora
Bulgarien
България
Bulleuze dermatitis (toxische epidermale necrolysis, Stevens Johnson syndroom, erythema multiforme, acuut gegeneraliseerde eczemateuze pustula (AGEP)), angio- oedeem, geneesmiddel geïnduceerd overgevoeligheids syndroom, geneesmiddelrash met eosinofilie en systemische symptomen (DRESS), erythemateuze of exfoliatieve rash, urticaria, eczeem, lichen planus
Bullous dermatitis (toxic epidermal necrolysis, Stevens Johnson Syndrome, erythema multiforme, acute generalised exanthematous pustulosis (AGEP)),
Bulløs dermatitis
s ***)
Bulløs dermatitis (toksisk epidermal nekrolyse, Stevens Johnson syndrom, erythema multiforme), akut generaliseret eksantematøs pustulose (AGEP), angioødem, lægemiddelinduceret overfølsomhedssyndrom,
Bullous dermatitis (toxic epidermal necrolysis, Stevens Johnson Syndrome, erythema multiforme, acute generalised exanthematous pustulosis (AGEP)),
Bulløs dermatitis (toksisk epidermal nekrolyse, Stevens Johnson Syndrom, erythema multiforme), angioødem
Bullous dermatitis (toxic epidermal necrolysis, Stevens Johnson Syndrome,
Bulløs dermatitis (toksisk epidermal nekrolyse, Stevens Johnson Syndrom, erythema multiforme), angioødem, erytematøst udslæt, urticaria, eksem, lichen planus
Bullous dermatitis (toxic epidermal necrolysis, Stevens Johnson Syndrome, erythema multiforme), angioedema, rash erythematous, urticaria, eczema, lichen planus
Bulløs dermatitis (toksisk epidermal nekrolyse, Stevens Johnsons syndrom, erythema multiforme), akut generaliseret eksantematøs pustulose (AGEP), angioødem, lægemiddelinduceret overfølsomhedssyndrom, medikamentelt udslæt med eosinofili og systemiske symptomer (DRESS), eller eksfoliativt erytematøst udslæt, urticaria, eksem, lichen planus
Bullous dermatitis (toxic epidermal necrolysis, Stevens Johnson Syndrome, erythema multiforme, acute generalised exanthematous pustulosis (AGEP)), angioedema, drug - induced hypersensitivity syndrome, drug rash with eosinophilia and systemic symptoms (DRESS), rash erythematous or exfoliative, urticaria, eczema, lichen planus
Bulløs dermatitis (toksisk epidermal nekrolyse, Stevens Johnsons syndrom, erythema multiforme), angioødem, lægemiddelinduceret overfølsomhedssyndrom, medikamentelt udslæt med eosinofili og systemiske symptomer (DRESS), erytematøst udslæt, urticaria, eksem, lichen planus
Bullous dermatitis (toxic epidermal necrolysis, Stevens Johnson Syndrome, erythema multiforme), angioedema, drug induced hypersensitivity syndrome, drug rash with eosinophilia and systemic symptoms (DRESS), rash erythematous, urticaria, eczema, lichen planus
Bulløs dermatitis (toksisk epidermal nekrolyse, Stevens- Johnson syndrom, erythema multiforme), akut generaliseret eksantematøs pustulose (AGEP), angioødem, lægemiddelinduceret overfølsomhedssyndrom, medikamentelt udslæt med eosinofili og systemiske symptomer (DRESS), erytematøst eller eksfoliativt udslæt, urticaria, eksem, lichen planus
Bullous dermatitis (toxic epidermal necrolysis, Stevens Johnson Syndrome, erythema multiforme, acute generalised exanthematous pustulosis (AGEP)), angioedema, drug-induced hypersensitivity syndrome, drug rash with eosinophilia and systemic symptoms (DRESS), rash erythematous or exfoliative, urticaria, eczema, lichen planus
Bulløs dermatitis (toksisk epidermal nekrolyse, Stevens- Johnsons syndrom, erythema multiforme), akut generaliseret eksantematøs pustulose (AGEP), angioødem, lægemiddelinduceret overfølsomhedssyndro m, medikamentelt udslæt med eosinofili og systemiske symptomer (DRESS), erytematøst eller eksfoliativt udslæt, urticaria, eksem, lichen planus
Bullous dermatitis (toxic epidermal necrolysis, Stevens Johnson Syndrome, erythema multiforme, acute generalised exanthematous pustulosis (AGEP)), angioedema, drug-induced hypersensitivity syndrome, drug rash with eosinophilia and systemic symptoms (DRESS), rash erythematous or exfoliative, urticaria, eczema, lichen planus
Bulløs dermatitis (toksisk epidermal nekrolyse, Stevens- Johnsons syndrom, erythema multiforme), akut generaliseret eksantematøs pustulose (AGEP), angioødem, lægemiddelinduceret overfølsomhedssyndrom, medikamentelt udslæt med eosinofili og systemiske symptomer (DRESS), erytematøst eller eksfoliativt udslæt, urticaria, eksem, lichen
Bullous dermatitis (toxic epidermal necrolysis, Stevens Johnson Syndrome, erythema multiforme, acute generalised exanthematous pustulosis (AGEP)), angioedema, drug-induced hypersensitivity syndrome, drug rash with eosinophilia and systemic symptoms (DRESS), rash erythematous or exfoliative, urticaria, eczema, lichen planus
Bulløs dermatitis (toksisk epidermal nekrolyse, Stevens- Johnsons syndrom, erythema multiforme), akut generaliseret eksantematøs pustulose (AGEP), angioødem, lægemiddelinduceret overfølsomhedssyndrom, medikamentelt udslæt med eosinofili og systemiske symptomer (DRESS), erytematøst eller eksfoliativt udslæt, urticaria, eksem, lichen planus
Bullous dermatitis (toxic epidermal necrolysis, Stevens Johnson Syndrome, erythema multiforme, acute generalised exanthematous pustulosis (AGEP)), angioedema, drug-induced hypersensitivity syndrome, drug rash with eosinophilia and systemic symptoms (DRESS), rash erythematous or exfoliative, urticaria, eczema, lichen planus
Bulløs dermatitis (toksisk epidermal nekrolyse, Stevens- Johnsons syndrom, erythema multiforme), angioødem lægemiddelinduceret overfølsomhedssyndrom, medikamentelt udslæt med eosinofili og systemiske symptomer (DRESS), erytematøst udslæt, urticaria, eksem, lichen planus
Bullous dermatitis (toxic epidermal necrolysis, Stevens Johnson Syndrome, erythema multiforme), angioedema, drug-induced hypersensitivity syndrome, drug rash with eosinophilia and systemic symptoms (DRESS), rash erythematous, urticaria, eczema, lichen planus
Bulløs dermatitis (toksisk epidermal nekrolyse, Stevens- Johnsons syndrom, erythema multiforme), angioødem, lægemiddelinduceret overfølsomhed, medikamentel udslæt med eosinofili og systemiske symptomer (DRESS), erytematøst eller eksfoliativt udslæt, urticaria, eksem, lichen planus
Bullous dermatitis (toxic epidermal necrolysis, Stevens Johnson Syndrome, erythema multiforme), angioedema, drug induced hypersentsitivity syndrome, drug rash with eosinophilia and systemic symptoms (DRESS), rash erythematous or exfoliative, urticaria, eczema, lichen planus
Bulløs dermatitis (toksisk epidermal nekrolyse, Stevens- Johnsons syndrom, erythema multiforme, akut generaliseret eksantematøs pustulose (AGEP)), angioødem, lægemiddelinduceret overfølsomhed, medikamentel udslæt med eosinofili og systemiske symptomer (DRESS), erytematøst eller eksfoliativt udslæt, urticaria, eksem, lichen planus, fast lokaliseret udbrud (fixed eruption)*
Bullous dermatitis (toxic epidermal necrolysis, Stevens Johnson Syndrome, erythema multiforme, acute generalised exanthematous pustulosis (AGEP)), angioedema, drug-induced hypersensitivity syndrome, drug rash with eosinophilia and systemic symptoms (DRESS), rash erythematous or exfoliative, urticaria, eczema, lichen planus, fixed eruption
Bulløs dermatitis (toksisk epidermal nekrolyse, Stevens- Johnsons syndrom, erythema multiforme, akut generaliseret eksantematøs pustulose (AGEP)), angioødem, lægemiddelinduceret overfølsomhed, medikamentel udslæt med eosinofili og systemiske symptomer (DRESS), erytematøst eller eksfoliativt udslæt, urticaria, eksem, lichen planus, fixed drug eruption*
Bullous dermatitis (toxic epidermal necrolysis, Stevens Johnson Syndrome, erythema multiforme, acute generalised exanthematous pustulosis (AGEP)), angioedema, drug-induced hypersensitivity syndrome, drug rash with eosinophilia and systemic symptoms (DRESS), rash erythematous or exfoliative, urticaria, eczema, lichen planus, fixed eruption
Bulløs dermatitis (toksisk epidermal nekrolyse, Stevens- Johnsons syndrom, erythema multiforme, akut generaliseret eksantematøs pustulose (AGEP)), angioødem, lægemiddelinduceret overfølsomhedssyndrom, medikamentelt udslæt med eosinofili og systemiske symptomer (DRESS), erytematøst eller eksfoliativt udslæt, urticaria, eksem, lichen planus
Bullous dermatitis (toxic epidermal necrolysis, Stevens Johnson Syndrome, erythema multiforme, acute generalised exanthematous pustulosis (AGEP)), angioedema, drug induced hypersensitivity syndrome, drug rash with eosinophilia and systemic symptoms (DRESS), rash erythematous or exfoliative, urticaria, eczema, lichen planus
Bulløs pemfigoid*
bullous pemphigoid
Bulløse eller eksfoliative hudlæsioner
Bullous or exfoliative skin lesions
Bulløse tilstande (hudsygdomme med blæredannelser), inklusive Stevens-Johnsons syndrom og toksisk epidermal nekrolyse
Bullous conditions (blistering skin diseases)-including Stevens-Johnson syndrome and Toxic epidermal necrolysis
Bulløse tilstande, inklusive toksisk epidermal nekrolyse, Stevens-Johnsons syndrom og erythema multiforme.
Bullous conditions including Toxic epidermal necrolysis, Stevens Johnson syndrome and erythema multiforme
Bulløst udslæ t, onykomykose, seborre, rosacea, hudpapilom, hyperkeratose, unormal hudpigmentering.
Bullous eruption, onychomycosis, seborrhoea, rosacea, skin papilloma, hyperkeratosis, abnormal skin pigmentation.
Bulløst udslæt, onykomykose, seborre, rosacea, hudpapilom, hyperkeratose, unormal hudpigmentering.
Bullous eruption, onychomycosis, seborrhoea, rosacea, skin papilloma, hyperkeratosis, abnormal skin pigmentation.
Bunden af kammeret SKAL være over den grå knap.
The bottom of the chamber MUST be above the grey button.
Bunden bærer et tryk med ”100 mg”, Schering- Plough-logoet og to striber.
The body is imprinted with "100 mg", the Schering-Plough logo and two stripes.
Bunden bærer et tryk med ”20 mg”, Schering- Plough-logoet og to striber.
The body is imprinted with "20 mg", the Schering-Plough logo and two stripes.
bundet med nefrotoksicitet.
associated with nephrotoxicity.
bundet med nefrotoksicitet.
nephrotoxicity.
buprenorphi
prenorphine
buprenorphin AUC ↑ 19 %
buprenorphine AUC ↑ 19
Buprenorphin AUC ↑67% Buprenorphin Cmax ↑37% Buprenorphin Cmin ↑69%
Buprenorphine AUC ↑67% Buprenorphine Cmax ↑37% Buprenorphine Cmin ↑69
buprenorphin AUC  11 % buprenorphin Cmin ↔ buprenorphin Cmax  8 % norbuprenorphin AUC ↑ 46 % norbuprenorphin Cmin ↑ 71 % norbuprenorphin Cmax ↑ 36 % naloxon AUC ↔ naloxon Cmin ND naloxon Cmax ↔
buprenorphine AUC ↓ 11% buprenorphine Cmin ↔ buprenorphine Cmax ↓ 8% norbuprenorphine AUC ↑ 46% norbuprenorphine Cmin ↑ 71% norbuprenorphine Cmax ↑ 36% naloxone AUC ↔ naloxone Cmin ND naloxone Cmax ↔
Buprenorphin blev titreret til en vedligeholdelsesdosis på Dag 3 – dosis af den aktive kontrol blev titreret mere gradvist.
Buprenorphine was titrated to maintenance dose by Day 3; active control doses were titrated more gradually.
Buprenorphin blev titreret til vedligeholdelsesdosis på Dag 3 – dosis af den aktive kontrol blev titreret mere gradvist.
Buprenorphine was titrated to maintenance dose by Day 3; active control doses were titrated more gradually.
buprenorphin Cmaks. ↑ 18 %
buprenorphine Cmax ↑ 18
buprenorphin Cmin ↑ 31 %
buprenorphine Cmin ↑ 31
buprenorphin eller efavirenz
not be necessary when
Buprenorphin i.v. og sublingual
Buprenorphine IV and sublingual
Buprenorphin ↔
Buprenorphine ↔
Buprenorphin ↔
Tipranavir ↔
buprenorphin*
treatment.
buprenorphin, der er et lægemiddel, som anvendes til behandling af kroniske smerter;
buprenorphine, a medicine used for the treatment of chronic pain;
Buprenorphin/naloxon
There are no
Buprenorphin/Naloxon (16/4 mg
Buprenorphine/Naloxone (16/4 mg
Buprenorphin/Naloxon (16/4 til
Buprenorphine/Naloxone (16/4 to
buprenorphin/naloxon (anvendes til behandling af stærke smerter)
buprenorphine/naloxone (medicines used to treat severe pain)
buprenorphin/naloxon (medicin til behandling af afhængighed af morfin og lignende)
Buprenorphine/naloxone (medicines to treat opiate dependence)
Buprenorphin/naloxon 8/2 mg–16/4 mg x 1
Buprenorphine/naloxone 8/2 mg–16/4 mg once daily
buprenorphin/naloxon eller
buprenorphine/naloxone
Buprenorphin/naloxon er kontraindiceret hos patienter med svært nedsat leverfunktion.
In patients with severe hepatic insufficiency the use of buprenorphine/naloxone is contraindicated.
Buprenorphin/naloxon kan forårsage alvorlig, eventuelt dødelig, respirationsdepression hos børn og ikke-afhængige personer i tilfælde af utilsigtet eller forsætlig indtagelse.
Buprenorphine/naloxone may cause severe, possibly fatal, respiratory depression in children and non- dependent persons in case of accidental or deliberate ingestion.
Buprenorphin/naloxon kan forårsage sløvhed, særligt ved samtidig indtagelse af alkohol eller CNS- supprimerende midler (såsom beroligende midler, sedativa eller hypnotika) (se pkt.
Buprenorphine/naloxone may cause drowsiness, particularly when taken together with alcohol or central nervous system depressants (such as tranquilisers, sedatives or hypnotics) (see section 4.5).
Buprenorphin/Naloxon*
Buprenorphine/Naloxone
buprenorphin/naloxon.
with buprenorphine/naloxone.
Buprenorphin/naloxon/ tenofovirdisoproxilfumarat
Buprenorphine/naloxone/Tenofovir disoproxil fumarate
Buprenorphin/naloxon/efavirenz
Implant: Etonogestrel/Efavirenz
Buprenorphin/naloxon/emtricitabin
Buprenorphine/naloxone/Emtricitabine
Buprenorphin:
IMMUNOSUPPRESSANTS
Buprenorphin: AUC: ↑ 1,5 gange Cmax: ↑ 1,7 gange
Buprenorphine: AUC: ↑ 1.5-fold Cmax: ↑1.7-fold
Buprenorphin: AUC: ↓ 50%
Buprenorphine: AUC: 0 50
Buprenorphin: AUC: ↓ 50%
Buprenorphine: AUC: ↓ 50
buprenorphineksponering
buprenorphine exposure, no
buprenorphineksponering udviste
buprenorphine exposure, no
Bupropion
Bosentan
Bupropion (CYP2B6-substrat)
Bupropion (CYP2B6 substrate)
Bupropion 150 mg 100 mg hver 12. ↓ 22% ↓ 21% time
150 100 q12h ↓ 22% ↓ 21
Bupropion 150 mg x 2
Bupropion 150 mg BID
Bupropion kontra placebo
Bupropion vs Placebo
Bupropion metaboliseres primært til dets aktive hovedmetabolit hydroxybupropion af CYP2B6- isozymet.
Bupropion is metabolised to its major active metabolite hydroxybupropion primarily by the CYP2B6 isozyme.
bupropion, der bruges til behandling af depression
bupropion, used for depression,
bupropion, der bruges til behandling af depression
bupropion, used for depression.
bupropion, der er et lægemiddel, som anvendes til at hjælpe dig med at holde op med at ryge
bupropion, a medicine used to help you stop smoking;
bupropion, der er et lægemiddel, som anvendes til at hjælpe dig med at holde op med at ryge;
bupropion, a medicine used to help you stop smoking;
Bupropion, medicin til behandling af depression eller til at hjælpe Dem med at holde op med at ryge, fordi Deres læge kan finde det nødvendigt at ændre Deres bupropiondosis.
Bupropion, a medicine used to treat depression or to help you stop smoking, as your doctor may need to change your dose of bupropion.
Bupropion, til behandling af depression samt til rygeafvænning.
Bupropion, used to treat depression and smoking cessation.
Bupropion/efavirenz [150 mg enkeltdosis (som depot)/600 mg én gang dagligt]
[150 mg single dose (sustained release)/600 mg once daily]
buproprion (anvendes til at behandle depression (nedtrykthed)) benzatropin (anvendes til at behandle Parkinsons sygdom)
buproprion (used to treat depression (sadness)) benzatropine (used to treat Parkinson’s disease)
Buproprion og dets aktive metabolit, hydroxybupropion: AUC og Cmax ↓ ~50%
Buproprion and its active metabolite, hydroxybupropion: AUC and Cmax ↓ ~50
Busilvex 6 mg/ml koncentrat til infusionsvæske, opløsning
Busilvex 6 mg/ml concentrate for solution for infusion
Busilvex 6 mg/ml koncentrat til infusionsvæske, opløsning busulfan
Busilvex 6 mg/ml concentrate for solution for infusion busulfan
Busilvex 6 mg/ml koncentrat til infusionvæske, opløsning
Busilvex 6 mg/ml concentrate for solution for infusion
Busilvex 6 mg/ml koncentrat til infusionvæske, opløsning busulfan
Busilvex 6 mg/ml concentrate for solution for infusion. busulfan.
Busilvex 6 mg/ml sterilt koncentrat IV
Busilvex 6 mg/ml sterile concentrate IV
Busilvex administreres i en dosis på 3,2 mg/kg som en enkelt daglig 3-timers infusion umiddelbart efter 2 eller 3 på hinanden følgende dage af fludarabin.
Busilvex will be administered at 3.2 mg/kg as a single daily three-hour infusion immediately after fludarabine for 2 or 3 consecutive days.
Busilvex anvendes til voksne og børn som en del af en ”konditionerende” (forberedende) behandling før transplantation af bloddannende progenitorceller (stamceller, der danner røde blodlegemer).
Busilvex is used in adults and children as part of a ‘conditioning’ (preparative) treatment before transplantation of haematopoietic progenitor cells (the cells that make blood cells).
Busilvex gives hver 6. time 4 dage i træk forud for transplantationen
Busilvex will be administered every 6 hours during 4 consecutive days prior to transplant.
Busilvex i kombination med fludarabin (FB) Voksne
Busilvex in combination with fludarabine (FB) In adults
Busilvex må ikke infunderes samtidig med anden intravenøs opløsning.
Busilvex must not be infused concomitantly with another intravenous solution.
Busilvex skal tilberedes af sundhedspersonale under anvendelse af steril overførselsmetode.
Busilvex must be prepared by a healthcare professional using sterile transfer techniques.
Busilvex tilsættes altid til infusionsvæsken, ikke infusionsvæsken til Busilvex.
Busilvex must always be added to the diluent, not the diluent to Busilvex.
Busilvex’ farmakokinetik er undersøgt.
The pharmacokinetics of Busilvex has been investigated.
Business Park, Citywest Road IRL-Dublin 24
Citywest Road IRL-Dublin 24
Buspiron Clorazepat Diazepam Estazolam Flurazepam
Buspirone Clorazepate Diazepam Estazolam Flurazepam
Buspiron Clorazepat Diazepam Estazolam Flurazepam Lorazepam Triazolam Zolpidem
Clorazepate Diazepam Estazolam Flurazepam Lorazepam Triazolam Zolpidem
Buspiron Ritonavir doseret som en farmakokinetisk forstærker eller som et antiretroviralt stof hæmmer CYP3A og forventes som følge heraf at øge plasmakoncentrationerne af buspiron.
Buspirone Ritonavir dosed as a pharmacokinetic enhancer or as an antiretroviral agent inhibits CYP3A and as a result is expected to increase the plasma concentrations of buspirone.
buspiron – anvendes som beroligende middel
buspirone - used to make you calmer
buspiron, clorazepat, diazepam, estazolam, flurazepam, midazolam, som ikke tages oralt, zoldipem (beroligende midler)
Buspirone, clorazepate, diazepam, estazolam, flurazepam, midazolam that is not taken orally, zoldipem (sedative agents)
buspiron, clorazepat, diazepam, estazolam, flurazepam, perphenazin, risperidon, thioridazin, zolpidem, lægemidler, der anvendes til at behandle lidelser i nervesystemet
buspirone, clorazepate, diazepam, estazolam, flurazepam, perphenazine, risperidone, thioridazine, zolpidem, medicines used to treat nervous system disorders
buspiron, clorazepat, diazepam, estazolam, flurazepam, zolpidem, lægemidler, der anvendes til at behandle lidelser i nervesystemet
buspirone, clorazepate, diazepam, estazolam, flurazepam, zolpidem, medicines used to treat nervous system disorders
Busulfan anvendes før transplantationen for at ødelægge abnorme celler og patientens eksisterende bloddannende celler.
Busulfan is used before transplantation to destroy abnormal cells and the patient’s existing blood- making cells.
Busulfan anvendes inden transplantation til at dræbe unormale celler og patientens eksisterende bloddannende progenitorceller.
Busulfan is used before transplantation to destroy abnormal cells and the patient’s existing haematopoietic progenitor cells.
Busulfan Fresenius Kabi 6 mg/ml koncentrat til infusionsvæske, opløsning
Busulfan Fresenius Kabi 6 mg/ml concentrate for solution for infusion
Busulfan Fresenius Kabi er et »generisk lægemiddel«.
Busulfan Fresenius Kabi is a ‘generic medicine’.
Busulfan Fresenius Kabi gives hver 6. time 4 dage i træk forud for transplantationen.
Busulfan Fresenius Kabi will be administered every 6 hours during 4 consecutive days prior to transplant.
Busulfan Fresenius Kabi i kombination med cyclophosphamid.
Busulfan Fresenius Kabi in combination with cyclophosphamide:
Busulfan Fresenius Kabi i kombination med fludarabin
Busulfan Fresenius Kabi in combination with fludarabine
Busulfan Fresenius Kabi kan også give symptomer på overgangsalder, og hos præ- teenagepiger kan det forhindre, at puberteten indtræder.
Busulfan Fresenius Kabi can also produce symptoms of menopause and in pre-adolescent girls it can prevent the onset of puberty.
Busulfan Fresenius Kabi må kun overføres til en infusionspose, som indeholder 9 mg/ml (0,9 %) natriumchlorid injektionsvæske eller 5 % glucose injektionsvæske.
Busulfan Fresenius Kabi must not be put into an intravenous bag that does not contain sodium chloride 9 mg/ml (0.9%) solution for injection or glucose solution for injection 5%.
Busulfan i kombination med cyclophosphamid eller melphalan
Busulfan in combination with cyclophosphamide or melphalan
Busulfan i kombination med cyclophosphamid Hos voksne
Busulfan in combination with cyclophosphamide In adults
Busulfan i kombination med fludarabin (FB) Hos voksne
Busulfan in combination with fludarabine (FB) In adults
Busulfan i kombination med fludarabin (FB) Til voksne
Busulfan in combination with fludarabine (FB) In adults